About: Antiangiogenic Drug Combination TL-118     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz:8890 associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Antiangiogenic Drug Combination TL-118
rdfs:subClassOf
Semantic_Type
  • Pharmacologic Substance
Preferred_Name
  • Antiangiogenic Drug Combination TL-118
NCI_META_CUI
  • CL433486
PDQ_Open_Trial_Search_ID
  • 723650
PDQ_Closed_Trial_Search_ID
  • 723650
FULL_SYN
  • Antiangiogenic Drug Combination TL-118PTNCI
  • TL-118CNNCI
  • Hamsa-1FBNCI
DEFINITION
  • A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal anti-inflammatory agent, an alkylating agent, a histamine H2 antagonist and a sulfonamide with potential anti-angiogenic and antineoplastic activities. Antiangiogenic drug combination TL-118 is administrated as a specific dosing regimen and may result in a synergistic effect and reduce angiogenesis and inhibit tumor cell proliferation.NCI
code
  • C99761
Faceted Search & Find service v1.16.121 as of Mar 31 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3240 as of Mar 31 2025, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 13 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software